These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2405193)

  • 1. Fibronectin distribution in normal and malignant urothelium.
    Grossman HB; Liebert M; Wedemeyer G; Wilson G; Flint A
    J Urol; 1990 Feb; 143(2):418-20. PubMed ID: 2405193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravesical Bacillus Calmette-Guérin therapy for murine bladder tumors: initiation of the response by fibronectin-mediated attachment of Bacillus Calmette-Guérin.
    Ratliff TL; Palmer JO; McGarr JA; Brown EJ
    Cancer Res; 1987 Apr; 47(7):1762-6. PubMed ID: 3545453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guérin interacts with the carboxyl-terminal heparin binding domain of fibronectin: implications for BCG-mediated antitumor activity.
    Cheng DL; Shu WP; Choi JC; Margolis EJ; Droller MJ; Liu BC
    J Urol; 1994 Oct; 152(4):1275-80. PubMed ID: 8072119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of fibronectin-mediated Bacillus Calmette-Guérin attachment to murine bladder mucosa by drugs influencing the coagulation pathways.
    Hudson MA; Brown EJ; Ritchey JK; Ratliff TL
    Cancer Res; 1991 Jul; 51(14):3726-32. PubMed ID: 2065329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of fibronectin in intravesical BCG therapy for superficial bladder cancer.
    Ratliff TL; Kavoussi LR; Catalona WJ
    J Urol; 1988 Feb; 139(2):410-4. PubMed ID: 3276931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibronectin expression on surgical specimens correlated with the response to intravesical bacillus Calmette-Guerin therapy.
    Fleischmann JD; Park MC; Hassan MO
    J Urol; 1993 Feb; 149(2):268-71. PubMed ID: 8426398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary fibronectin in diagnosis and follow-up of patients with urinary bladder cancer.
    Malmström PU; Larsson A; Johansson S
    Br J Urol; 1993 Sep; 72(3):307-10. PubMed ID: 8220992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface distribution of fibronectin in cultures of fibroblasts and bladder derived epithelium: SEM-immunogold localization compared to immunoperoxidase and immunofluorescence.
    Trejdosiewicz LK; Smolira MA; Hodges GM; Goodman SL; Livingston DC
    J Microsc; 1981 Aug; 123(Pt 2):227-36. PubMed ID: 7035678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction.
    Garden RJ; Liu BC; Redwood SM; Weiss RE; Droller MJ
    J Urol; 1992 Sep; 148(3):900-5. PubMed ID: 1512857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.
    Kavoussi LR; Brown EJ; Ritchey JK; Ratliff TL
    J Clin Invest; 1990 Jan; 85(1):62-7. PubMed ID: 2404029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of mouse monoclonal antibody B1.4 reactive with human invasive bladder cancer and some other malignant tumors but not with normal urinary epithelium.
    Saiki S; Kinouchi T; Kuroda M; Uenaka A; Nakayama E; Kotake T
    Jpn J Cancer Res; 1994 Jul; 85(7):756-61. PubMed ID: 8071117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans.
    Mitropoulos D; Petsis D; Kyroudi-Voulgari A; Kouloukoussa M; Zervas A; Dimopoulos C
    Nitric Oxide; 2005 Aug; 13(1):36-41. PubMed ID: 15964223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of nitric oxide in bacillus Calmette-Guérin mediated anti-tumour effects in human bladder cancer.
    Jansson OT; Morcos E; Brundin L; Lundberg JO; Adolfsson J; Söderhäll M; Wiklund NP
    Br J Cancer; 1998 Sep; 78(5):588-92. PubMed ID: 9744496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma.
    Messing EM
    Cancer Res; 1990 Apr; 50(8):2530-7. PubMed ID: 1690599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro particulate adherence to fibronectin: correlation with in vivo particulate adherence to sites of bladder injury.
    See WA; Rohlf DP; Crist SA
    J Urol; 1992 May; 147(5):1416-23. PubMed ID: 1569698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of fibronectin distribution pattern in solid human tumours.
    Labat-Robert J; Birembaut P; Robert L; Adnet JJ
    Diagn Histopathol; 1981; 4(4):299-306. PubMed ID: 7040003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo.
    Chester JD; Kennedy W; Hall GD; Selby PJ; Knowles MA
    Gene Ther; 2003 Jan; 10(2):172-9. PubMed ID: 12571646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary fibronectin levels in patients treated with intravesical bacillus Calmette-Guérin for superficial bladder cancer.
    Danişman A; Bulut K; Kukul E; Ozen I; Sevük M
    Urol Int; 2000; 64(4):198-201. PubMed ID: 10895085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involucrin, a marker of squamous and urothelial differentiation. An immunohistochemical study on its distribution in normal and neoplastic tissues.
    Walts AE; Said JW; Siegel MB; Banks-Schlegel S
    J Pathol; 1985 Apr; 145(4):329-40. PubMed ID: 3889247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the fibronectin-binding ability and antitumor efficacy of various mycobacteria.
    Hudson MA; Ritchey JK; Catalona WJ; Brown EJ; Ratliff TL
    Cancer Res; 1990 Jul; 50(13):3843-7. PubMed ID: 2191767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.